POSTnote by Peter Border. It was first published on Friday, 3 February 2012. It was last updated on Friday, 3 February 2012.
Biomedical Patents
In October 2011, the European Court of Justice banned patents for inventions involving stem cells derived from embryos. This case highlighted some of the challenges the patent system faces when assessing biomedical inventions. This POSTnote considers how patent law is applied to biomedical inventions and examines the potential impact on patient access to diagnostic tests and innovation.
Secondary information
- Type
- Research briefing
- Reference
- POST-PN-401
- Subjects
- DNA Human embryo experiments Medical treatments Patents Medicine Screening Technology Stem cells Human-animal hybrid embryos
- Published by
- POST
- Link
- View this Research briefing on researchbriefings.parliament.uk
Librarians' tools
- Timestamp
- 2016-02-07 22:17:43 +0000
- URI
- http://data.parliament.uk/resources/345022
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/resources/345022
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/resources/345022
- Internal location
- http://researchbriefings.intranet.parliament.uk/ResearchBriefing/Summary/POST-PN-401